je.st
news
Tag: biopharma
UPDATE 1-Samsung biopharma unit mulling NASDAQ listing to raise about $1.34 bln
2015-06-29 07:07:13| Semiconductors - Topix.net
Samsung Bioepis Co Ltd, a biopharmaceutical development unit of Samsung Group, is considering listing on the NASDAQ to raise about 1.5 trillion won to fund product development, a Bioepis spokeswoman said on Monday. Samsung Bioepis is 90 percent owned by Samsung Biologics, which is in turn 46 percent owned by Samsung Electronics Co Ltd , 46 percent by the group's de facto holding company Cheil Industries Inc and about 6 percent owned by builder and general trader Samsung C&T Corp Cheil Industries and Samsung C&T are in the midst of a proposed $8 billion merger that has been opposed by activist U.S. hedge fund Elliott Associates.
Tags: update
listing
unit
raise
UPDATE 1-Samsung biopharma unit mulling NASDAQ listing to raise about $1.34 bln
2015-06-29 04:51:11| Chemicals - Topix.net
Samsung Bioepis Co Ltd, a biopharmaceutical development unit of Samsung Group, is considering listing on the NASDAQ to raise about 1.5 trillion won to fund product development, a Bioepis spokeswoman said on Monday. Samsung Bioepis is 90 percent owned by Samsung Biologics, which is in turn 46 percent owned by Samsung Electronics Co Ltd , 46 percent by the group's de facto holding company Cheil Industries Inc and about 6 percent owned by builder and general trader Samsung C&T Corp Cheil Industries and Samsung C&T are in the midst of a proposed $8 billion merger that has been opposed by activist U.S. hedge fund Elliott Associates.
Tags: update
listing
unit
raise
Thermo Fisher Scientific Drives Innovation And Productivity For Laboratories, Biopharma At ACHEMA 2015
2015-06-15 07:36:46| chemicalonline Home Page
ACHEMA 2015– (June 15, 2015) – Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing its latest innovations designed to accelerate life science research and increase productivity for biosciences and bioprocessing
Tags: scientific
drives
innovation
productivity
Array BioPharma sells Longmont facility to Minnesota firm
2015-06-02 15:07:13| Biotech - Topix.net
Boulder drug research company Array BioPharma Inc. said it's sold its chemistry, manufacturing and controls business in Longmont to Accuratus Lab Services of Minnesota for an undisclosed price. The 50,000-square-foot Longmont facility employs 33 former Array BioPharma workers and the location will now be known as Avista Pharma Solutions.
Tags: firm
facility
minnesota
array
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG ...
2015-06-02 11:00:25| Trucking - Topix.net
Celldex Therapeutics, Inc. shares rose more than +10% in pre-market trading to $32.01 after the biopharmaceutical company released data on a study indicating that an experimental vaccine was effective in patients with brain cancer. The 12-month consensus target price on TipRanks for Celldex is $37.23, marking a 29% potential upside based on current levels.
Tags: monday
morning
corp
insights
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »